
Tefazoline
Tefazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Tefazoline is a antihistaminic or local vasoconstrictor, antazoline derivative. Tefazoline has a monoisotopic molecular weight of 214.15 Da. — DrugBank
- IUPAC name
- 2-(5,6,7,8-tetrahydronaphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole
- Molecular formula
- C14H18N2
- Molecular weight
- 214.31 g/mol
- Exact mass
- 214.146998583 Da
- XLogP3
- 2.2
- Topological polar surface area
- 24.4 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 1
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
9 more reported names
External database identifiers
- ChEMBL:CHEMBL2107059
- EPA DTXSID:DTXSID40862528
Evidence from additional scientific databases
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record
Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.
Additional source coverage and match status
| Source | Result | Checked |
|---|---|---|
| NIH PubChem PUG-View | Exact match | 2026-08-31 |
A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.